Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a diverse disease that can be categorized based on a combination of genetic risk factors and autoantibodies. It is characterized by inflammatory changes in the synovial tissue of joints, as well as cartilage and bone, and in some cases, other parts of the body as well. Over time, these inflammatory changes can lead to joint dysfunction, deformity, and chronic pain.

Mesenchymal stem cells (MSCs) possess significant potential to differentiate into various cell types, including adipocytes (fat cells), chondrocytes (cartilage cells), and osteoblasts (bone-forming cells). Alongside their regenerative properties, MSCs also exhibit unique immunomodulatory characteristics. These properties offer new possibilities in the treatment of autoimmune diseases, including RA, and make MSCs a promising tool in stem cell-based therapies.

Rheumatoid arthritis

Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References